Reliv International, Inc. (Nasdaq: RELV), a developer, manufacturer and marketer of a proprietary line of nutritional supplements, has expanded its Scientific Advisory Board with the addition of two new members with sterling international reputations: pharmacologist James Jamieson of St. Louis and nutraceutical expert Dr. Clare M. Hasler of Davis, Calif.
“These two scientists bring tremendous experience to Reliv. Their expertise complements the expertise of our other Scientific Advisory Board members, both of whom are physicians,” said Reliv Vice President Dr. Carl W. Hastings, who heads the company’s research and development. “The Reliv Scientific Advisory Board reviews potential new ingredients, evaluates new products and provides recommendations to support Reliv’s research,” Hastings said.
No comments yet.